Lack of α-synuclein does not alter apoptosis of neonatal catecholaminergic neurons

European Journal of Neuroscience

Volumn 20, Issue 7, 2004, Pages 1969-1972

  Stefanis, Leonidas ^a,b   Wang, Qiaohong ^a   Oo, Tinmarla ^a   Lang Rollin, Isabelle ^a   Burke, Robert E ^a   Dauer, William T ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b Found Biomed Res Acad Athens   (Greece)

Author keywords

Apoptosis; Dopaminergic neuron; Mouse; Parkinson's disease; Sympathetic neurons

Indexed keywords

ALPHA SYNUCLEIN; NERVE GROWTH FACTOR; PROTEIN C JUN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CATECHOLAMINE NERVE CELL; CELL LINE; CELL LOSS; CONTROLLED STUDY; GENE OVEREXPRESSION; MOUSE; NEWBORN; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SUBSTANTIA NIGRA; SYMPATHETIC NERVE CELL;

ALPHA-SYNUCLEIN; ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; BASE SEQUENCE; DISEASE MODELS, ANIMAL; DNA PRIMERS; MICE; MICE, KNOCKOUT; NERVE TISSUE PROTEINS; NEURITES; NEURONS; PARKINSON DISEASE; PHOSPHOPROTEINS; POLYMERASE CHAIN REACTION; SYNUCLEINS;

EID: 8144229351     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2004.03638.x     Document Type: Article

References (27)

1. Abeliovich, A., Schmilz, Y., Farinas, I., Choi-Lundberg, D., Ho, W.H., Castillo, P.E., Shinsky, N., Verdugo, J.M., Armanini, M., Ryan, A., Hynes, M., Phillips, H., Sulzer, D. & Rosenthal, A. (2000) Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system. Neuron, 25, 239-252.
2. Cabin, D.E., Shimazu, K., Murphy, D., Cole, N.B., Gottschalk, W., McIlwain, K.L., Orrison, B., Chen, A., Ellis, C.E., Paylor, R., Lu, B. & Nussbaum, R.L. (2002) Synaptic vesicle depletion correlates with attenuated synaptic responses to prolonged repetitive stimulation in mice lacking alpha-synuclein. J. Neurosci., 22, 8797-8807.
3. Clayton, D.F. & George, J.M. (1998) The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease. TINS, 21, 249-254.
4. da Costa, C.A., Ancolio, K. & Checler, F. (2000) Wild-type but not Parkinson's disease-related ala-53 → Thr mutant alpha-synuclein protects neuronal cells from apoptotic stimuli. J. Biol. Chem., 275, 24065-24069.
5. da Costa, C.A., Masliah, E. & Checler, F. (2003) Beta-synuclein displays an antiapoptotic p53-dependent phenotype and protects neurons from 6-hydroxydopamine-induced caspase 3 activation: cross-talk with alpha-synuclein and implication for Parkinson's disease. J. Biol. Chem., 278, 37330-37335.
6. da Costa, C.A., Paitel, E., Vincent, B. & Checler, F. (2002) Alpha-synuclein lowers p53-dependent apoptotic response of neuronal cells. Abolishment by 6-hydroxydopamine and implication for Parkinson's disease. J. Biol. Chem., 277, 50980-50984.
7. Dauer, W., Kholodilov, N., Vila, M., Trillat, A.C., Goodchild, R., Larsen, K.E., Staal, R., Tieu, K., Schmitz, Y., Yuan, C.A., Rocha, M., Jackson-Lewis, V., Hersch, S., Sulzer, D., Przedborski, S., Burke, R. & Hen, R. (2002) Resistance of alpha-synuclein null mice to the parkinsonian neurotoxin MPTP. Proc. Natl Acad. Sci. USA, 99, 14524-14529.
8. Deshmukh, M. & Johnson, E.M. Jr (1997) Programmed cell death in neurons: focus on the pathway of nerve growth factor deprivation-induced death of sympathetic neurons. Mol. Pharmacol., 51, 897-906.
9. Eilers, A., Whitfield, J., Shah, B., Spadoni, C., Desmond, H. & Ham, J. (2001) Direct inhibition of c-Jun N-terminal kinase in sympathetic neurones prevents c-jun promoter activation and NGF withdrawal-induced death. J. Neurochem., 76, 1439-1454.
10. Goers, J., Manning-Bog, A.B., McCormack, A.L., Millett, I.S., Doniach, S., Di Monte, D.A., Uversky, V.N. & Fink, A.L. (2003) Nuclear localization of alpha-synuclein and its interaction with histones. Biochemistry, 42, 8465-8471.
11. Hashimoto, M., Hsu, L.J., Rockenstein, E., Takenouchi, T., Mallory, M. & Masliah, E. (2002) alpha-Synuclein protects against oxidative stress via inactivation of the c-Jun N-terminal kinase stress-signaling pathway in neuronal cells. J. Biol. Chem., 277, 11465-11472.
12. Kholodilov, N.G., Neystat, M., Oo, T.F., Lo, S.E., Larsen, K.E., Sulzer, D. & Burke, R.E. (1999) Increased expression of rat synuclein in the substantia nigra pars compacta identified by mRNA differential display in a model of developmental target injury. J. Neurochem., 73, 2586-2599.
13. Kholodilov, N., Yarygina, O., Oo, T.F., Zhang, H., Sulzer, D., Dauer, W. & Burke, R.E. (2004) Regulation of the development of mesencephalic dopaminergic systems by the selective expression of glial cell line-derived neurotrophic factor in their targets. J. Neurosci., 24, 3136-3146.
14. Lee, M., Hyun, D., Halliwell, B. & Jenner, P. (2001) Effect of the overexpression of wild-type or mutant alpha-synuclein on cell susceptibility to insult. J. Neurochem., 76, 998-1009.
15. Manning-Bog, A.B., McCormack, A.L., Li, J., Uversky, V.N., Fink, A.L. & Di Monte, D.A. (2002) The herbicide paraquat causes up-regulation and aggregation of alpha-synuclein in mice: paraquat and alpha-synuclein. J. Biol. Chem., 277, 1641-1644.
16. Manning-Bog, A.B., McCormack, A.L., Purisai, M.G., Bolin, L.M. & Di Monte, D.A. (2003) Alpha-synuclein overexpression protects against paraquat-induced neurodegeneration. J. Neurosci., 23, 3095-3099.
17. Maroney, A.C., Finn, J.P., Bozyczko-Coyne, D., O'Kane, T.M., Neff, N.T., Tolkovsky, A.M., Park, D.S., Van, C.Y., Troy, C.M. & Greene, L.A. (1999) CEP-1347 (KT7515), an inhibitor of JNK activation, rescues sympathetic neurons and neuronally differentiated PC12 cells from death evoked by three distinct insults. J. Neurochem., 73, 1901-1912.
18. Mori, F., Tanji, K., Yoshimoto, M., Takahashi, H. & Wakabayashi, K. (2002) Immunohistochemical comparison of alpha- and beta-synuclein in adult rat central nervous system. Brain Res., 941, 118-126.
19. Oo, T.F. & Burke, R.E. (1997) The time course of developmental cell death in phenotypically defined dopaminergic neurons of the substantia nigra. Dev Brain Res., 98, 191-196.
20. Oo, T.F., Kholodilov, N. & Burke, R.E. (2003) Regulation of natural cell death in dopaminergic neurons of the substantia nigra by striatal GDNF in vivo. J. Neurosci., 23, 5141-5148.
21. Ostrerova, N., Petrucelli, L., Farrer, M., Mehta, N., Choi, P., Hardy, J. & Wolozin, B. (1999) alpha-Synuclein shares physical and functional homology with 14-3-3 proteins. J. Neurosci., 19, 5782-5791.
22. Rideout, H.J., Dietrich, P., Savalle, M., Dauer, W.T. & Stefanis, L. (2003) Regulation of alpha-synuclein by bFGF in cultured ventral midbrain dopaminergic neurons. J. Neurochem., 84, 803-813.
23. Rochet, J.C., Conway, K.A. & Lansbury, P.T. Jr (2000) Inhibition of fibrillization and accumulation of prefibrillar oligomers in mixtures of human and mouse alpha-synuclein. Biochemistry, 39, 10619-10626.
24. Seo, J.H., Rah, J.C., Choi, S.H., Shin, J.K., Min, K., Kim, H.S., Park, C.H., Kim, S., Kim, E.M., Lee, S.H., Lee, S., Suh, S.W. & Suh, Y.H. (2002) Alpha-synuclein regulates neuronal survival via Bcl-2 family expression and PI3/Akt kinase pathway. FASEB J., 16, 1826-1828.
25. Stefanis, L., Kholodilov, N., Rideout, H.J., Burke, R.E. & Greene, L.A. (2001) Synuclein-1 is selectively up-regulated in response to nerve growth factor treatment in PC12 cells. J. Neurochem., 76, 1165-1176.
26. Vekrellis, K., Rideout, H.J. & Stefanis, L. (2004) Neurobiology of α-synuclein. Mol. Neurobiol., 30, 1-21.
27. Vila, M., Vukosavic, S., Jackson-Lewis, V., Neystat, M., Jakowec, M. & Przedborski, S. (2000) Alpha-synuclein up-regulation in substantia nigra dopaminergic neurons following administration of the parkinsonian toxin MPTP. J. Neurochem., 74, 721-729.